Opseu Pension Plan Trust Fund Regeneron Pharmaceuticals, Inc. Transaction History

Opseu Pension Plan Trust Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $24,106 - $30,421	42 Added 0.84%	5,048 $3.68 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $1.72 Million - $2.32 Million	3,138 Added 167.99%	5,006 $2.94 Million
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $39,873 - $46,794	67 Added 3.72%	1,868 $1.3 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $19,565 - $24,154	36 Added 2.04%	1,801 $1.12 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $49,940 - $59,243	-87 Reduced 4.7%	1,765 $1 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $53,899 - $63,673	114 Added 6.56%	1,852 $1.09 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $27,250 - $33,440	61 Added 3.64%	1,738 $819,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $88,963 - $113,084	186 Added 12.47%	1,677 $817,000
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $18,521 - $22,379	34 Added 2.33%	1,491 $827,000
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $439,054 - $573,088	890 Added 156.97%	1,457 $896,000
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $190,614 - $280,341	567 New	567 $274,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.